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Metabolism of Halogenated Ethylenes
by Kenneth C. Leibman*t and Elsa Ortiz*
The metabolism of the chlorinated ethylenes may be explained by the formation of chloroethylene
epoxides as the first intermediate products. The evidence indicates that these epoxides rearrange with
migration of chlorine to form chloroacetaldehydes and chloroacetyl chlorides. Thus, monochloroacetic
acid, chloral hydrate, and trichloroacetic acid have been found in reaction mixtures of
1,1-dichloroethylene, trichloroethylene, and tetrachloroethylene, respectively, with rat liver microsomal
systems. Rearrangements of the chloroethylene glycols formed from the epoxides by hydration may also
take place, but would appear, at least in the case of 1,1-dichloroethylene, to be quantitatively less
important. The literature on the metabolism of chlorinated ethylenes and its relationship to their toxicity
is reviewed.
Introduction
The demonstration that the carbon-carbon dou-
ble bond in olefins (1-4), cyclic olefins (3), and
aromatic compounds (5) are oxidized to epoxides
by the mixed-function oxidases of mammalian liver
microsomes has generated much interest in the
metabolism of unsaturated compounds and its rela-
tionship to their toxicity. The epoxide ring tends to
be chemically quite unstable, depending upon the
configuration ofthe oxirane compound. It may thus
react with a variety of groups in compounds of
biological interest; when these compounds are es-
sential to cellular function, such reaction may lead
to alteration of cellular metabolism and subsequent
cell necrosis, or to carcinogenic or mutagenic
events.
Epoxides may be detoxified by hydration to
diols, a reaction catalyzed by microsomal epoxide
hydrase (6-8), or by reaction with soluble
glutathione-epoxidetransferases with the ultimate
production of mercapturic acids (9). Arene oxides
may also rearrange to phenols (10).
Early studies with chlorinated olefins (11, 12)
demonstrated the metabolic formation of products
in which transfer ofchlorine atoms from one carbon
atom to another had taken place. The most likely
pathway for such product formation would be via
epoxidation of the double bond. The resulting
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halo-oxirane compounds are known to be extraor-
dinarily unstable and rearrange spontaneously at
rapid rates (13). Haloglycols that might be formed
from such haloepoxides by enzymic or nonenzymic
hydration would also be quite unstable, due to the
presence of halogen and oxygen functions on the
same carbon atoms, and would be expected to un-
dergo rapid reactions analogous to the pinacol rear-
rangement. The recent discovery of the
hepatotoxic, carcinogenic, and mutagenic poten-
tials of a number of chlorinated ethylenes (14-18)
has prompted new interest in the pathways of
metabolism of these compounds.
We propose to review the literature on the
metabolic transformations of the various chlori-
nated ethylenes, and to present in detail some ofour
own more recent work (19) on the products of
metabolism of some of these compounds in vitro.
We shall not discuss the metabolism of vinyl
chloride, as this is the subject of several reports at
this conference.
Trichloroethylene
Trichloroethylene was the first halogenated
ethylene of which the metabolism was studied.
After inhalation of this compound by dogs, the
urine was found to contain trichloroacetic acid (20)
and trichloroethanol (21), the latter both free and
conjugated with glucuronic acid. These metabolites
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many experimental animals after exposure to tri-
chloroethylene (22). One report exists ofthe excre-
tion of small amounts of monochloroacetic acid by
man after inhalation of trichloroethylene (23).
Butler (24) noted that the end products of
metabolism of chloral hydrate and of trichlo-
roethylene are identical, and he postulated (21) that
chloral hydrate is an intermediate in the production
of trichloroacetic acid and trichloroethanol from
trichloroethylene. He was unable, however, to dem-
onstrate the presence ofchloral hydrate in dogs that
had been exposed to trichloroethylene.
Proof for Butler's hypothesis was provided by
the demonstration in our laboratory that the first
stable, nonvolatile product of biotransformation of
trichloroethylene in rat liver preparations is chloral
hydrate. The identity of the product was estab-
lished by a variety of chromatographic, colorimet-
ric, chemical, and enzymic methods (12). The reac-
tion was shown to be catalyzed by liver microsomes
in the presence of a NADPH-generating system,
and to behave as a typical mixed-function
oxidase-mediated process (25). Formation of
chloral hydrate from trichloroethylene was found to
be stimulated in preparations from animals pre-
treated with phenobarbital or chronically exposed
to trichloroethylene (26) and to be inhibited by
metyrapone (27) and carbon monoxide (28). Fur-
thermore, trichloroethylene produces a type 1 dif-
ference spectrum when added to liver microsomes
(28, 29). The magnitude of type 1 binding of tri-
chloroethylene is enhanced by pretreatment of ani-
mals with phenobarbital but not by that with
3-methylcholanthrene (29); chloral hydrate for-
mation would therefore appear to involve cyto-
chrome P-450 rather than cytochrome P-448.
The microsomal production of chloral hydrate
from trichloroethylene in liver microsomes has
been confirmed by Ikeda and Imamura (30), and
chloral hydrate has since been found in the plasma
of rats (31) and humans (32) inhaling trichlo-
roethylene, and to be produced in the isolated rat
liver upon perfusion with trichloroethylene (13).
The enzymic pathway for metabolism of tri-
chloroethylene was thus established, inasmuch as
the enzymic mechanisms of conversion of chloral
hydrate to trichloroethanol and trichloroacetic acid
had already been demonstrated. The former pro-
cess is catalyzed by liver alcohol dehydrogenase
(33), whereas the oxidation of chloral hydrate to
trichloroacetic acid is mediated by a NAD-
requiring dehydrogenase in liver which is different
from aldehyde dehydrogenase (34). That chloral
hydrate is an intermediate in the formation of
trichloroacetic ccid, trichloroethanol, and the
glucuronide of the latter was confirmed by the
demonstration that urinary excretion ofthese prod-
ucts by rats exposed to trichloroethylene was in-
creased when the animals were pretreated with
phenobarbital (26). Production of trichlorinated
urinary metabolites is also enhanced after pre-
treatment with polychlorinated biphenyls, but not
with 3-methylcholanthrene, hexachlorobenzene,
spironolactone, or pregnenolone-166a-carbonitrile
(18).
We therefore proposed the scheme shown in Eqs.
(1) for the microsomal metabolism of trichlo-
roethylene (12). In this hypothetical pathway,
C12C=CHC1
'" W C13C-CHO_--Cl3C-CH(OH)2
C12C-CHCI \Hj>" C12CH-COCl--.Cl2CH-COOH
OH OH
I1 0 C13C-CH(OH)2 C12C-CHC1' (I)
trichloroethylene is converted to its epoxide by the
microsomal mixed-function oxidase system. The
action of microsomal epoxide hydrase would con-
vert this epoxide to trichloroethylene glycol. Rear-
rangement of the glycol by a reaction analogous to
the pinacol rearrangement would produce chloral
hydrate. Rearrangement of the epoxide with migra-
tion ofchlorine would yield chloral, which would be
hydrated immediately. If the epoxide were to rear-
range with migration of a hydrogen atom, the prod-
uct would be dichloroacetyl chloride, which would
be hydrolyzed rapidly to dichloroacetic acid. It is of
interest to note that the latter rearrangement is the
one that normally occurs spontaneously in aqueous
solutions, and that the presence of Lewis acids is
required for the formation ofchloral. By use of two
gas-chromatographic systems (see below), we have
been unable to detect the presence ofdichloroacetic
acid in extracts of incubation mixtures containing
trichloroethylene, rat liver microsomes, and a
NADPH-generating system, in which the forma-
tion ofchloral hydrate could be demonstrated. Simi-
larly, Bonse et al. (13) found chloral hydrate, but no
dichloroacetic acid, after perfusion of isolated rat
livers with trichloroethylene. It may be concluded
that, if rearrangement of trichloroethylene oxide is
involved in chloral hydrate formation, a directive
influence ofsome microsomal component is exerted
upon the ring opening.
Recent work on the metabolic activation of tri-
chloroethylene also suggests that an epoxide is an
intermediate in its metabolism. Van Duuren and
Banerjee (35) have shown that after incubation of
trichloro['4C]ethylene with rat liver microsomes in
the presence of a NADPH-generating system, 14C
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binding was decreased when inhibitors of mi-
crosomal drug oxidation were present, and was in-
creased in magnitude when the rats had been pre-
treated with phenobarbital, which enhances both
the rate of metabolism (18, 26, 29) and the
hepatotoxicity (18, 36) oftrichloroethylene. The ex-
tent of covalent binding was diminished when vari-
ous sulfhydryl compounds, which can react with
epoxides, were present, and it was increased in the
presence of 1,2-epoxy-3,3,3-trichloropropane,
which is a known inhibitor of epoxide hydrase. All
the evidence thus far obtained, therefore, may be
explained by the primary formation of tri-
chloroethylene oxide, which may react with tissue
constituents, rearrange to chloral, or be hydrated to
a glycol.
Tetrachloroethylene
The next chlorinated ethylene for which
metabolic studies were reported was tetrachlo-
roethylene. In 1961, Yllner reported on the urinary
metabolites of mice exposed to tetrachloro[V4C]-
ethylene (11). Of the total urinary radioactivity,
52% was present as trichloroacetic acid, 11% as ox-
alic acid, and a trace as dichloroacetic acid. No
labeled monochloroacetic acid, formic acid, or tri-
chloroethanol was found. However, 18% of the
radioactivity was not extractable with ether, even
after hydrolysis of the urine. Daniel (37) adminis-
tered [36C1] tetrachloroethylene orally to rats, and
found only labeled trichloroacetic acid and inor-
ganic chloride, in equimolar proportions, in the
urine. These workers proposed that tetrachloro-
ethylene oxide was the first product of metabolism,
followed by rearrangement to trichloroacetyl
chloride.
Trichloroacetic acid has since been observed to
be a urinary metabolite of tetrachloroethylene in
experimental animals and humans (18, 38-44). The
excretion of total trichloro compounds, as mea-
sured by the Fujiwara colorimetric reaction after
oxidation, exceeded that of trichloroacetic acid; in
some cases this was assumed to be trichloroethanol
(42, 43), whereas in other investigations it could not
be demonstrated to be this compound (41). In one
report, ethylene glycol was claimed to be a prom-
inent metabolite (38).
By analogy with the metabolism of trichlo-
roethylene, we have proposed (19) a scheme for pos-
sible pathways ofmetabolism oftetrachloroethylene
[Eqs. (2)]. The primary reaction is hypothesized to
be the formation of tetrachloroethylene oxide by
mixed-function oxidation, followed by hydration of
the oxide to trichloroethylene glycol. Because of
C'2C==Cc'2
C12C -CC12
12> C13C-COC1-.-C13C-COOH
C12C CC12
Cl3C-COCI---*Cl3C-COOH
OH OH (2)
the symmetry of these products, rearrangement of
either would yield only one product, trichloroacetyl
chloride, which would be hydrolyzed rapidly to
trichloroacetic acid. To test this hypothesis, we
have set up two gas-chromatographic systems that
allow the separation and quantitation ofmono-, di-,
and trichloroacetic acids (Table 1). When extracts
of incubation mixtures of tetrachloroethylene and
rat liver 9000g supernatant fraction with a
NADPH-generating system were analyzed by
Table 1. Gas chromatographic retention times
of possible acidic metabolites."
Column Retention Times, sec
MCA DCA TCA
Chromosorb 101
1950C 318 786
1050C 882
10% DC-560
650C (TMS) 264
1050C (TMS) 228
"Chromosorb 101 was used without coating. DC-560 was on
Chromosorb P-AW-DMCS. Both were 80/100 mesh, in 1.8 m x
2 mm glass U-columns. For preparation of the trimethylsilyl
(TMS) derivatives, 10 /LI ofpyridine was added to ether extracts,
which were then dried over anhydrous MgSO,, and the ether
evaporated under a stream of nitrogen at room temperature. 50
,ul of Pierce Tri-Sil was added, and 10 min later an aliquot was
injected into the gas chromatograph. MCA, DCA, TCA denote
mono-, di-, and trichloroacetic acids, respectively.
either method, a peak corresponding in retention
time to that of trichloroacetic acid was obtained in
an area of the chromatogram that was devoid of
peaks in those ofblank incubation mixtures to which
tetrachloroethylene was not added until the end of
the incubation, immediately before extraction. When
the extracts were "spiked" with trichloroacetic
acid, only one peak was observed. No mono- or
dichloroacetic acid could be detected.
Trichloroacetic acid could also be quantitated by
the sensitive modification of the Fujiwara alkaline
pyridine method devised in our laboratory several
years ago (45). When this method was used for the
estimation ofthe trichloroacetic acid produced from
tetrachloroethylene, the results were very similar to
those obtained by the gas-chromatographic method
(Table 2). The effects of various additives on the
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tetrachloroethylene in rat liver 9000g supernatant fraction."
Method TCA, nmole
Gas chromatography 154
Colorimetric assay 148
aIncubation mixtures contained, in a total of 5 ml, 100 ,umole
of nicotinamide, 3 ,umole of ATP, 6 ,amole of EDTA, 25 ,umole
of glucose 6-phosphate, 50 ,umole of MgSO,, 0.3 ,umole of
NADP+ 98 j,mole of tetrachloroethylene, I mmole of Tris buf-
fer (pH 7.5), and reconstituted lyophilized 9000g supernatant
fraction from 400 mg of liver from rats that had been pretreated
with phenobarbital, 75 mg/kg, for 3 days. After incubation for 2
hr at 37°C, mixtures were chilled on ice for 10 min. For gas
chromatography, the chilled mixtures were saturated with NaCI,
adjusted to pH 1 with HCl, and extracted with 5 ml ofether; the
extracts were evaporated to 100 ,ul at room temperature under a
stream of dry nitrogen, and aliquots were injected into the gas
chromatograph. For colorimetric analysis, the chilled incubation
mixtures were deproteinized with 0.5 ml of 10%o Na2WO4 and 0.5
ml of 2N H2SO,, and aliquots of the supernatant liquid were
subjected to procedure A ofthe modified Fujiwara reaction (45).
reaction are shown in Table 3. EDTA, ATP, and
nicotinamide all had small enhancing enfects when
magnesium ions were present. Surprisingly, mag-
nesium ion inhibited trichloroacetic acid production
at a concentration (10 mM) that enhances most mi-
crosomal oxidations, including the production of
chloral hydrate from trichloroethylene (25). In the
absence of magnesium, EDTA had no significant
effect, whereas ATP and nicotinamide still en-
Table 3. Production of trichloroacetic acid from
tetrachloroethylene in rat liver 9000g supernatant fraction.
System % of control
Complete, with Mg++a 100
less EDTA 73
less ATP 83
less nicotinamide 75
less Mg++ 186
Complete, without Mg++ 100
less EDTA 106
less ATP 79
less nicotinamide 78
aThe complete system as described in Table 2.
hanced the reaction rate slightly. Table 4 shows that
the nucleotide-generating system was required for
production of trichloroacetic acid from tetra-
chloroethylene; NADH substituted very poorly for
NADPH, and no synergism was observed when
the two reduced nucleotides were present together.
Finally, Table 5 shows that when cyclohexene was
added to the incubation mixture to inhibit epoxide
hydrase, no difference in trichloroacetic acid forma-
tion was observed. It may be concluded that, ifthe
epoxide-diol pathway is operative, either tri-
chloroethylene oxide is not subject to hydration by
epoxide hydrase, or else both the epoxide and the
glycol are rearranged to trichloroacetyl chloride at
similar rates.
Bonse et al. (13) also found trichloroacetic acid to
be the only detectable metabolite in isolated rat
liver perfused with tetrachloroethylene. Trichlo-
roacetic acid was found free in the perfusate, and
could also be extracted from the liver after vigorous
acid hydrolysis. They postulated that trichlo-
roacetyl chloride reacted with cell constituents, re-
sulting in acylation. This may be the cause of the
hepatotoxicity of tetrachloroethylene noted by
Moslen et al. (18). They showed that pretreatment
with polychlorinated biphenyls increased both the
production of trichloroacetic acid and the level of
serum transaminase after exposure to tetrachlo-
roethylene. Greim et al., however, did not find tet-
rachloroethylene to be mutagenic to bacteria after
incubation with liver microsomes and a NADPH-
generating system (16).
Table 4. Coenzyme requirement for conversion of
tetrachloroethylene to trichloroacetic acid
in rat liver microsomes.a
Generating system TCA formed, nmole
None 0
NADPH 80.1
NADH 5.5
NADPH + NADH 86.9
aIncubation conditions were similar to those ofTable 2, except
that microsomes from 400 mg of liver were used. For the
NADPH-generating system, 2 units ofglucose 6-phosphate de-
hydrogenase were added. For the NADH-generating system,
NADP+ was replaced by an equal quantity of NAD+, glucose
6-phosphate by I ,ul of ethanol, and glucose 6-phosphate dehy-
drogenase by 2 units of alcohol dehydrogenase.
Table 5. Effect ofepoxide hydrase inhibition on production
of trichloroacetic acid from tetrachloroethylene.a
Cyclohexene oxide TCA formation,
M % of control
5x 1O-5 96
5 x 10-4 107
5 x 1O-3 81
alncubation conditions as described in Table 2.
1,1-Dichloroethylene
The metabolism of 1,1-dichloroethylene (vinyl-
idene chloride) had apparently not been studied prior
to 1975 (46). By analogy to the metabolism of
trichloroethylene, we postulated the pathway (19)
shown in Eqs. (3). If the epoxide-diol pathway is
Cl2C=CH2
H r CIOC-CH2CI----HOOC-CH2CI
C-CH-C1CH-3( H CCl2C-CH2 C
[I 2 ]c} CIOC-CH2CI---*HOOC-CH2CI
OH OH- (3)
Environmental Health Perspectives 94operative, rearrangement of the glycol, or of the
epoxide with migration of a chlorine atom, should
give rise to monochloroacetyl chloride, which
would then be hydrolyzed to monochloroacetic
acid. Rearrangement of the epoxide with migration
of a hydrogen atom would yield dichloroacetal-
dehyde. We were able to demonstrate the presence
of monochloroacetic acid in extracts of incubation
mixtures of 1,1-dichloroethylene with rat liver
9000g supernatant fraction and a NADPH-
generating system by both of the above-mentioned
gas-chromatographic systems. No dichloroacetic
acid was detected. However, another peak was
present in the chromatogram of the underivatized
extract, which as yet is unidentified; we have not
been successful in obtaining a satisfactory gas
chromatogram from samples of dichloroacetal-
dehyde freshly prepared from its acetal.
As seen in Table 6, the production of mono-
chloroacetic acid from l,l-dichloroethylene is ex-
tensively inhibited by magnesium ion. EDTA en-
hanced the reaction in the presence or absence of
magnesium; ATP was required in the presence but
not the absence of magnesium, whereas the op-
posite was the case with nicotinamide. The sig-
Table 6. Production of monochloroacetic acid from
1,1-dichloroethylene in rat liver 9000g supernatant fraction.a
System % of control
Complete, with Mg++ 100
less EDTA 14
less ATP 0
less nicotinamide 124
less Mg++ 1800
Complete, without Mg++ 100
less EDTA 14
less ATP 96
less nicotinamide 23
alncubation conditions were similar to those ofTable 2, except
that tetrachloroethylene was replaced by 132 Amole of
1,l-dichloroethylene.
nificance of these observations is not clear at pres-
ent.
Table 7 shows that the NADPH-generating sys-
tem is required for monochloroacetic acid produc-
tion and cannot be replaced by a NADH-generating
system. As shown in Table 8, inhibition ofepoxide
Table 7. Coenzyme requirement for conversion of
1,1-dichloroethylene to monochloroacetic acid
in rat liver microsomes.a
Generating system MCA formed, nmole
None 0
NADPH 856
NADH 0
NADPH + NADH 880
aincubation conditions were similar to those ofTable4, except
that tetrachloroethylene was replaced by 132 ,umole of
1,I-dichloroethylene.
hydrase by either cyclohexene oxide or 1,2-
epoxy-3,3,3-trichloropropane results in stimulation
of the formation of monochloroacetic acid to about
double the control value; higher concentrations of
the inhibitors apparently interfere with the epoxida-
tion reaction. We may conclude that the larger part
of the monochloroacetic acid is formed by rear-
rangement of the epoxide, and that the glycol is
relatively unimportant as a source of monochlo-
Table 8. Effect of epoxide hydrase inhibition on production
of monochloroacetic acid from 1,1-dichloroethylene.a
Concentration, MCA formation,
Inhibitor M % of control
Cyclohexene oxide 5 + 10-4 111
5 x 10-3 209
3 x 10-2 102
1,2-Epoxy-3,3,3- 5 x 10-5 107
trichloropropane 5 x 10-4 200
5 x 10-3 181
aConditions were as in Table 6.
roacetic acid. Inhibition of the conversion of the
epoxide to the glycol therefore allows the accumu-
lation of the epoxide and a greater rate of produc-
tion of monochloroacetic acid from the epoxide.
The relationship of the metabolism of
1,1-dichloroethylene to its toxicity is not clear. The
mutagenicity of this compound to bacteria in the
presence of liver microsomes requires a NADPH-
generating system and is increased when the rodent
donors of the microsomes are pretreated with
phenobarbital (47). However, pretreatment with
phenobarbital or polychlorinated biphenyls has
been reported to protect experimental animals from
the hepatotoxicity caused by 1,1-dichloroethylene
(48, 49). Unlike the case of vinyl chloride, the
hepatotoxicity of which shows a positive correla-
tion with hepatic microsomal cytochrome P-450
content, the hepatotoxicity of l,1-dichloroethylene
shows a negative correlation with cytochrome
P-450 levels (49). Jaeger et al. have shown that the
hepatotoxicity of 1,1-dichloroethylene is greatest
under conditions in which liver glutathione levels
are lowest (15, 50, 51). Ifthis hepatotoxicity is due,
not to the epoxide metabolite but to 1,1-dichlo-
roethylene per se, a reaction between glutathione
and the chloroethylene may be catalyzed by
glutathione S-alkenetransferase (9). Alternatively,
differential induction ofmicrosomal mixed-function
oxidase and epoxide hydrase activities by pheno-
barbital may greatly increase the diol/epoxide ratio
in this case, which would reduce the hepatotoxicity
ifthis were caused by the epoxide. As noted above,
hydration of 1,1-dichloroethylene oxide would ap-
pear to be subject to inhibition; it would be interest-
ing to test the effect of these inhibitors on the
hepatotoxicity of 1,1-dichloroethylene.
95 December 19771,2-Dichloroethylene
A scheme for the metabolism of 1,2-dichloro-
ethylene, analogous to those presented above, is
shown in Eqs. (4). One might expect the production
of dichloroacetaldehyde by rearrangement of the
CICH=CHCI
1; C12CH-CHO
CICH-CHCI
_\ J/( CICH2--COCI1- CICH2-COOH
FC1CH-CHCIl
C12CH-CH(OH)2
L OH OH (4)
glycol or ofthe epoxide with migration ofa chlorine
atom, or of monochloroacetyl chloride, and there-
fore monochloroacetic acid, by rearrangement with
migration of a hydrogen atom. We have found no
significant amounts ofmonochloroacetic acid in ex-
tracts of incubation mixtures of either cis- or
trans-1,2-dichloroethylene with rat liver 9000g
supernatant fraction and aNADPH-generating sys-
tem. A chromatographic peak was obtained from
experiments with either isomer that was similar in
retention time to the unknown peak obtained in
experiments with 1,l-dichloroethylene. Attempts to
identify this peak as dichloroacetaldehyde have
been inconclusive.
Bonse et al. (13) have demonstrated the produc-
tion ofsmall quantities ofdichloroacetic acid and of
dichloroethanol in the isolated rat liver perfused
with either cis- or trans-1,2-dichloroethylene. By
analogy with the metabolism of trichloroethylene,
this may indicate the initial formation of di-
chloroacetaldehyde.
In summary, it has been demonstrated that di-,
tri-, and tetrachloroethylenes are converted in liver
microsomes to products that may be explained by
assuming that the first reaction is the formation of
an epoxide bridge at the double bond, and that the
resulting chloroethylene oxide rearranges, with
migration of a chlorine atom, to yield an aldehyde
or acyl halide. Rearrangement of the glycol formed
from the epoxide by hydration may also be involved
but, at least in the case of 1,I-dichloroethylene, this
reaction would appear to be quantitatively less im-
portant.
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